产品名称
(+)-S-三苯甲基-L-半胱氨酸, 97%
Quality Level
assay
97%
optical activity
[α]25/D +115°, c = 0.8 in 0.04 M ethanolic HCl
reaction suitability
reaction type: solution phase peptide synthesis
mp
182-183 °C (dec.) (lit.)
application(s)
peptide synthesis
SMILES string
N[C@@H](CSC(c1ccccc1)(c2ccccc2)c3ccccc3)C(O)=O
InChI
1S/C22H21NO2S/c23-20(21(24)25)16-26-22(17-10-4-1-5-11-17,18-12-6-2-7-13-18)19-14-8-3-9-15-19/h1-15,20H,16,23H2,(H,24,25)/t20-/m0/s1
InChI key
DLMYFMLKORXJPO-FQEVSTJZSA-N
Application
(+)-S-三苯甲基 -L-半胱氨酸是一种非天然的含硫氨基酸,通常用作液相多肽合成(SPPS)中的溶剂。它还可用作金属结合剂,用于以 HBTU 肽偶联剂通过肽-金属相互作用合成可用于阳离子传感应用解决方案的取代的二茂铁酰肽偶联物。
Sébastien Brier et al.
Journal of molecular biology, 360(2), 360-376 (2006-06-20)
The mitotic kinesin Eg5 plays an essential role in establishing the bipolar spindle. Recently, several antimitotic inhibitors have been shown to share a common binding region on Eg5. Considering the importance of Eg5 as a potential drug target for cancer
James A D Good et al.
Journal of medicinal chemistry, 56(5), 1878-1893 (2013-02-12)
The mitotic kinesin Eg5 is critical for the assembly of the mitotic spindle and is a promising chemotherapy target. Previously, we identified S-trityl-L-cysteine as a selective inhibitor of Eg5 and developed triphenylbutanamine analogues with improved potency, favorable drug-like properties, but
Frank Kozielski et al.
Proteomics, 8(2), 289-300 (2008-01-11)
Mitotic kinesins represent potential drug targets for anticancer chemotherapy. Inhibitors of different chemical classes have been identified that target human Eg5, a kinesin responsible for the establishment of the bipolar spindle. One potent Eg5 inhibitor is S-trityl-L-cysteine (STLC), which arrests
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| S1515-.2ML | 04061837724305 |
| S3396-.2ML | 04061837724459 |
| 164739-5G | 04061838748294 |
